Position in HLN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$736,332
+$190,337 QoQ
Shares Held
78,921
+44.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#162
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $28,058,357 across 19 Drug Manufacturers - Specialty & Generic names. HLN ranks #10 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
64,199 | $7,122,237 | |
| 2 | PCRX |
Pacira BioSciences, Inc.
|
127,996 | $3,247,258 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
5,625 | $3,047,793 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
87,650 | $2,969,582 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
79,024 | $2,739,762 | |
| 6 | ZTS |
Zoetis Inc.
|
34,463 | $2,476,511 | |
| 7 | VTRS |
Viatris Inc
|
140,952 | $2,238,317 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
6,718 | $1,132,251 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $736,332 | 78,921 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $545,995 | 54,545 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $556,636 | 55,058 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $484,442 | 54,007 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $477,642 | 46,060 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $532,723 | 51,771 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $547,815 | 57,423 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $664,402 | 62,798 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $606,358 | 73,409 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $606,610 | 71,450 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $642,976 | 78,126 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $701,227 | 84,181 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $740,867 | 88,409 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $771,240 | 94,747 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $837,720 | 104,715 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $666,550 | 109,450 | Shares | Sole | 2022-10-17 | |
| No filing history on record for this holder in this stock. | ||||||